Analysts have modestly increased their price target for Hanover Insurance Group from $199.43 to $199.71. They cite slightly stronger revenue growth projections that offset a minor dip in profit margin estimates.
What's in the News
- The Hanover Insurance Group launched HSIP Advantage, a specialized property product for businesses handling high-hazard products. The new offering features modular coverage and simplified policy language. (Key Developments)
- From July 1 to October 27, 2025, the company repurchased 323,000 shares as part of its ongoing buyback program. This brings the total to over 22% of shares repurchased since 2018. (Key Developments)
- The company expanded its Business Owner's Advantage product to serve more life sciences organizations, including early-stage and smaller companies. The expansion introduces new coverage options and a streamlined digital platform. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target increased modestly from $199.43 to $199.71.
- Discount Rate has risen slightly from 6.78% to 6.96%.
- Revenue Growth estimates edged higher from 4.55% to 4.88%.
- Net Profit Margin estimates declined marginally from 8.45% to 8.40%.
- Future P/E multiple increased slightly from 13.13x to 13.17x.
Have other thoughts on Hanover Insurance Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.